Nomura et al. from Towa Pharmaceutical evaluated the respective impacts of NO₂ and NO on the nitrosation of pharmaceuticals. This study is a follow-up to their previous work, which investigated the use of chemical filters to reduce atmospheric nitrogen oxides during pharmaceutical manufacturing. According to their experimental results, NO₂, rather than NO, had a significant impact on the nitrosation reaction. These findings provide further evidence supporting the effectiveness of removing NO₂ with chemical filters as a strategy to mitigate nitrosamine formation.
https://pubs.acs.org/doi/10.1021/acs.oprd.6c00108
ABSTRACT:
We have previously clearly identified atmospheric nitrogen oxides (NOx) as a key factor in nitrosamine contamination in pharmaceuticals. To implement more appropriate countermeasures, the nitrosation potential of nitrogen monoxide (NO) and nitrogen dioxide (NO2)─the primary components of NOx─was evaluated using short-term and long-term gas flow model experiments. The results revealed that NO2 is required for the nitrosation reaction to occur.